Boehringer Secures FDA Approval For High-Concentration Cyltezo – But Without Interchangeability

The Formulation Did Not Receive The Designation Despite Meeting Requirements

 
• By Adam Zamecnik
  
Boehringer Ingelheim sign
• Source: Shutterstock
Generics Bulletin Podcast

Stay ahead of every shift in generics and biosimilars.

Generics Bulletin brings you the latest updates that matter for the off-patent industry.

SpotifyApple PodcastsWebsite

More from Biosimilars

More from Products